Downregulation of human FGF8 activity by antisense constructs in murine fibroblastic and human prostatic carcinoma cell systems

Oncogene

Volumn 16, Issue 11, 1998, Pages 1487-1492

  Rudra Ganguly, Nandini ^a   Zheng, Jianping ^a   Hoang, Arthur T ^a   Roy Burman, Pradip ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antisense RNA; FGF8; Prostate cancer cells; Retroviral vector

Indexed keywords

FIBROBLAST GROWTH FACTOR; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CARCINOMA CELL; CELL GROWTH; CELL STRAIN 3T3; CLONOGENESIS; DOWN REGULATION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

ANIMALIA; MURINAE; MUS MUSCULUS; UNIDENTIFIED RETROVIRUS;

EID: 0032546230     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201652     Document Type: Article

References (30)

1. Basilico C and Moscatelli D. (1992). Adv. Cancer Res., 59, 115-165.
2. Blunt AG, Lawshé A, Cunningham ML, Seto ML, Ornitz DM and MacArthur CA. (1997). J. Biol. Chem., 272, 3733-3738.
3. Coulier F, Pontarotti P, Roubin R, Hartung H, Goldfarb M and Birnbaum D. (1997). J. Mol. Evol., 44, 43-56.
4. Crossley PH and Martin GR. (1995). Development, 121, 439-451.
5. Crossley PH, Minowada G, MacArthur CA and Martin GR. (1996). Cell., 84, 127-136.
6. Freytag SO, Paielli DL and Gilbert JD. (1994). Genes and Develop., 8, 1654-1663.
7. Gemel J, Gorry M, Ehrlich GD and MacArthur CA. (1996). Genomics, 35, 253-257.
8. Ghosh AK, Shankar DB, Shackleford GM, Wu K, T'Ang A, Miller GJ, Zheng J and Roy-Burman P. (1996). Cell Growth Diff., 7, 1425-1434.
9. Gibson I. (1996). Cancer Metastasis Res., 15, 287-299.
10. Gleave ME, Hsieh J-T, Gao C-A, von Eschenbach AC and Chung LWK. (1991). Cancer Res., 51, 3753-3761.
11. Gleave ME, Hsieh J-T, von Eschenbach AC and Chung LWK. (1992). J. Urol., 147, 1151-1159.
12. Hickinheimo M, Lawshé A, Shackleford GM, Wilson DB and MacArthur CA. (1994). Mech. Dev., 48, 129-138.
13. Johnson DE and Williams LT. (1993). Adv. Cancer Res., 60, 1-41.
14. Junker U, Rittner K, Homann M, Bevec D, Bohnlein E and Sczakiel G. (1994). Antisense Res. Dev., 4, 165-172.
15. Kobayashi M, Yamauchi Y, Yamaguchi K and Tanaka A. (1995). Antisense Res. Dev., 5, 141-148.
16. Kouhara H, Koga M, Kasayama S, Tanaka A, Kishimoto T and Sato B. (1994). Oncogene, 9, 455-462.
17. Leung HY, Dickson C, Robson CN and Neal DE. (1996). Oncogene, 12, 1833-1835.
18. Lorenzi MV, Long JE, Miki T and Aaronson SA. (1995). Oncogene, 10, 2051-2055.
19. MacArthur CA, Lawshé A, Shankar DB, Heikinheimo M and Shackleford GM. (1995a). Cell Growth Diff., 6, 817-825.
20. MacArthur CA, Lawshé A, Xu J, Santos-Ocampo S, Heikinheimo M, Chellaiah AT and Ornitz DM. (1995b). Development. 121, 3603-3613.
21. MacArthur CA, Shankar DB and Shackleford GM. (1995c). J. Virol., 69, 2501-2507.
22. Mahmood R, Bresnick J, Hornbruch A, Mahony C, Morton N, Colquhoun K, Martin P, Lumsden A, Dickson C and Mason I. (1995). Current Biol., 5, 797-806.
23. Mason IJ. (1994). Cell, 78, 547-552.
24. Ohuchi H, Yoshioka H, Tanaka A, Kawakami Y, Nohno T and Noji S. (1994). Biochem. Biophys. Res. Commun., 204, 882-888.
25. Payson RA, Wu J, Liu Y and Chiu I-M. (1996). Oncogene, 13, 47-53.
26. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H and Matsumoto K. (1992). Proc. Natl. Acad. Sci. USA, 89, 8928-8932.
27. Tanaka A, Miyamoto K, Matsuo H, Matsumoto K and Yoshida H. (1995). FEBS Lett., 363, 226-230.
28. Verdier A-S, Mattei M-G, Lovec H, Hartung H, Goldfarb M, Birnbaum D and Coulier F. (1997). Genomics, 40, 151-154.
29. White RA, Dowler LL, Angeloni SV, Pasztor LM and MacArthur CA. (1995). Genomics, 30, 109-111.
30. Yan G, Fukabori Y, Nikolaropoulas S, Wang F and McKeehan WL. (1992). Mol. Endocrinol., 6, 2123-2128.